Measles outbreak means my immunocompromised son can’t leave the house without extreme safety measures - Top-Institutions - MDSpire

Measles outbreak means my immunocompromised son can’t leave the house without extreme safety measures

  • By

  • Penelope Gatlin

  • April 20, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Boston Children's Hospital
    Boston Children's Hospital

    Boston, MA

    Key Differentiators

    • Pediatric Immunology
    • Rare Genetic Disorders
    • Infectious Diseases

  • #2

    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Infectious Diseases
    • Rare Genetic Disorders

  • #3

    Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical Center

    Cincinnati, OH

    Key Differentiators

    • Pediatric Immunology
    • Rare Diseases
    • Infectious Diseases

  • #4

    Johns Hopkins Children's Center
    Johns Hopkins Children's Center

    Baltimore, MD

    Key Differentiators

    • Pediatric Immunology
    • Rare Genetic Disorders
    • Infectious Diseases

  • #5

    Seattle Children's Hospital
    Seattle Children's Hospital

    Seattle, WA

    Key Differentiators

    • Pediatric Immunology
    • Rare Diseases
    • Infectious Diseases

Original Source(s)

Measles outbreak means my immunocompromised son can’t leave the house without extreme safety measures

  • by Penelope Gatlin

  • April 20, 2026

Related Content

Bivalent virus-like particles expressing SPECT1 and CSP trigger pre-erythrocytic malaria immunity and protect against transgenic Plasmodium falciparum sporozoite challenge in mice

Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis

Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update